A Phase I, Single- And Multiple-Dose, Relative Bioavailability and Pharmacokinetic Study of Encapsulated Mesalamine [mesalazine] Granules Administered Orally to Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 13 Jul 2018
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Bausch Health Companies; Salix Pharmaceuticals
- 25 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Mar 2008 New trial record.